MedTech Business - August 27, 2013
RaySearch lands first Raystation order in China
In July, RaySearch Laboratories AB received regulatory market approval by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation and has now gotten the first order. The order was received from Ganzhou People’s Hospital in Ganzhou, Jiangxi Province, China where it will be used for treatment planning of both conventional treatments and IMRT. “China is one […]
Acquisition - August 26, 2013
MedImmune buys Amplimmune
The AstraZeneca unit MedImmune acquires US biotech company for up to $500 million. Amplimmune is based in Maryland and focuses on developing novel therapeutics in cancer immunology. According to AstraZeneca, the acquisition will bolster MedImmune’s oncology pipeline by obtaining multiple early-stage assets for its immune-mediated cancer therapy (IMT-C) portfolio, including AMP-514, an anti-programmed cell death 1 (PD-1) monoclonal […]
Uncategorized - August 23, 2013
Doing business in Brazil
The constantly developing life science market in Brazil was discussed at the Swedish-American Life Science Summit. Day three of the Swedish-American Life Science Summit, SALSS, continued with presentations, seminars and discussions. One of the day’s topics was the opportunities in the Brazilian Market. Steven Burrill, CEO of Burrill & Company, acted as moderator of a […]
Uncategorized - August 23, 2013
EU gold label to Danish life science network
Biopeople, the Danish Innovation Network for Health & Life Sciences, has been awarded with the Cluster Management Excellence Gold Label. Biopeople is part of the Danish infrastructure for innovation established and co-funded by the Ministry of Science, Innovation and Higher Education. It embraces and clusters universities, research organisations and hospitals, the Danish Health and Medicines Authority, industry associations as […]
Uncategorized - August 22, 2013
Addressing aging at SALSS
The challenges of global aging are one agenda as the ninth edition of SALSS takes place in the Swedish capital. According to tradition, the annual Swedish-American Life Science Summit opened during an evening reception. On the summer evening of August 21, the festivities started off at the Hotell Kung Karl Banquet. Special recognition was given […]
Acquisition - August 22, 2013
L2S firm collaborates with Pfizer
L2S AB, a life science company specialized in interactive cognitive behavioural therapy, has signed an international agreement with Pfizer. L2S, Learning 2 Sleep AB, is a Minc company based in Malmö with three part-owners. The company was founded in 2010 and provides services based on CBT treatment of sleeping disorders. One of the first services from […]
